However, these conditions account for about 11% of all child deaths globally, while pneumonia and diarrhoea are jointly responsible for nearly half of all child deaths (5). This is about the same as the number of deaths from smoking, double the total number of deaths from HIV/AIDS and is 25 times the number of deaths from war globally. Despite this huge mortality, we recently found a steep decreasing trend in research publications on the global extent of these problems reflecting reduced research interest and investment over the past 2 decades (6) ( Figure 1 ). This was in line with the report of the Global Forum for Health
We propose that a major reason for these failures has been the lack of recognition that low coverage is a challenge for health research, to identify effective and efficient context-specific delivery mechanisms in health services of countries with limited resources. The development and proof of effective interventions has been seen in the past as the legitimate endpoint of research. Implementation research that needs to follow (including health policy and systems research and delivery research) is methodologically challenging and may require long-term studies. It has not been ranked as highly by the scientific community or by most funding agencies as new work in basic science or intervention development. This has tragic consequences. It has been shown that up to two thirds of under-five child deaths globally could be prevented today if available and cost-effective interventions were delivered to those in need (10) . This would achieve UN's Millennium Development Goal 4, and is affordable within current global financial resources (10, 12) .
We believe that this experience with these two forgotten killers is a good predictor of what can be expected to occur in the future if the current research investment model is to persist (Figure 2 ). Effective new interventions such as vaccines against AIDS, TB or malaria may be developed in the coming decade, but the same challenge will then be faced: how to make those vaccines cheaper and more cost-effective, and how to deliver them to those most in need? The potential public health impact of these new interventions will not be realised without research on implementation.
The dominant model of research priority setting is resulting in gross under-achievement of potential disease burden reduction and is actually generating further health inequity. Current major global funding initiatives favour the areas of research interest of the scientists involved in basic research, thus investing into options which have received the greatest level of advocacy and media coverage and whose future potential outputs appear most attractive to these communities and the agencies which support them. This is further encouraged by the greater potential for publications in high-impact journals, which is a major indicator of research quality, and also funding in the current research policy model (Figure 2 ). When these new research avenues lead to the successful development of new interventions, the initial beneficiaries usually are those who can afford the results of the research. More complete coverage of the population in need often lags decades behind (12) (13) (14) . It is apparent that global research priorities and media pressure fuelled by an interest in highly unusual individual cases or emerging but uncertain threats are bound to generate ever increasing inequity. We believe that a major underlying problem is lack of clear principles for health research investment based on a vision of what the endpoints of such investments should be.
We need a framework which values investment not only in generating new knowledge, but also in research that seeks to define how to implement and make better use of the existing knowledge leading to public health impact on burden of disease
A New Model of Priority Setting for Global Health Research Investments
The Commission on Health Research for Development was the most significant initial development in setting research priorities globally (15) . It reviewed global health needs and priorities for health research in 1990 and concluded that "...less than 10% of global health research funds is devoted to 90% of the world's health problems" (13) The major conceptual advance in this initiative is the recognition that there should be a broader definition of health research option as an activity that is not only limited to producing new knowledge, but also has a vision of implementation of this knowledge which, in the end, should help to reduce disease burden present today. From this it follows that it is important not to consider the endpoint of research as "generating new and interesting knowledge or insight", because this necessarily favours more fundamental research. Rather, the process of research priority setting should have a clear theoretical framework based on multiple endpoints coupled to a systematic process of scoring and ranking competing research options.
In Figure 2 , we illustrate the alternative model proposed by CHNRI, which addresses several components of a research option that can be used as criteria for setting research priorities: (i) likelihood that research option would be answerable in ethical way; (ii) likelihood that resulting intervention would be effective in reducing disease burden; (iii) deliverability, affordability and sustainability of resulting intervention; (iv) maximum potential of intervention to reduce disease burden; and (v) effect of disease burden reduction on equity in population. We believe it is also important to acknowledge that there are three different instruments of health research (IHRs, Figure 3 ). For example, health policy and systems research will reduce disease burden by improving efficiency of health systems in delivering the interventions, implementation research will aim to improve existing non-affordable interventions to make them feasible and affordable in low-income settings, while other types of research will seek new and non-existing interventions. The former two types of research are not as innovative and attractive as the latter one, and their results are unlikely to be publishable in journals of high impact, but they nevertheless carry a significant potential to reduce the existing disease burden.
We are concerned that the current research priority decision making is not driven by an explicit framework and value system and thus is too open to research interest bias of individuals who influence funding priorities in large donor agencies without an unbiased vision focused on reducing disease burden and improving global health inequities. The six main advantages of the CHNRI methodology presented in Figure 3 over the alternative approaches are: (i) it is systematic, and technical experts involved the process to set research priorities are asked to list and score competing research options in a highly structured way; this limits the influence of their own personal biases on the outcome, which is frequently a problem in Delphi studies; (ii) the methodology is entirely transparent; all rationales for decision making and input from each person involved from the initial to the final stages are recorded, displayed and can be viewed and challenged at any later point in time; (iii) the experts submit their input into the process independently from each other, and the results are based on their collective opinion in a true sense, thus avoiding the possibility of some individuals among them directing the process; (iv) the final result is a simple quantitative outcome ("research priority score"), which measures the "value" of each research option when all the criteria and stakeholders' views are taken into account; this "value" can then be combined with the proposed cost of research in order to perform program budgeting and marginal analysis and derive an optimal mix of research options to be funded from a fixed budget; (v) the methodology is well suited to simultaneously evaluate and score different types of research (e.g. health policy and systems research, implementation research and research on new interventions) using the same set of criteria; (vi) unlike all previous approaches, this methodology incorporates an efficient means of considering the voice of stakeholders and wider public, who are given the power to place thresholds and weights upon Table 1 , we present final scores and rankings of those research options that addressed pneumonia and diarrhoea. Eight research options addressing those two diseases were placed among the top 13 research priorities, thus correctly recognizing the magnitude of their effect on mortality burden in South Africa. Furthermore, the priorities identified were dominated by health policy and systems research options to increase the coverage of the simplest and most cost-effective interventions, such as hand-washing, breastfeeding and increased usage of antibiotic treatment of pneumonia (Table 1) .
Although all initiatives aiming to set priorities and invest in child health research in developing countries are welcome, it is important to understand that without an explicit consideration of the issues listed above, the health gains that can be achieved will be limited.
There are signs that these issues are beginning to gain attention. Some examples include the Research Assessment Exercise in the UK, a major driver of research priorities in public sector, debating how to respond to criticisms that the system undervalues health systems research; the European Commission, announcing that there will be a new funding stream for Health Policy and Systems Research in the forthcoming 7 year research programme (FP7) and, in the field of pneumonia, the grants by the Global Alliance for Vaccines and Immunisation for public-private partnerships and related research to accelerate the achievement of high levels of population coverage of immunisation with the new Hemophilus influenzae type b and pneumococcal protein conjugate vaccines. These initiatives are welcome but there is a need for a new framework for global health research priority setting, especially in child health research. We believe that only in this way will proper attention be given to delivery of proven interventions to reduce the high childhood mortality due to pneumonia and diarrhoea. 
